Yang Jun, Xiong Jun, Yuan Ting, Wang Xue, Jiang Yunfeng, Zhou Xiaohong, Liao Kai, Xu Lingling
Jiangxi University of TCM, Nanchang, Jiangxi, China.
The Affiliated Hospital of Jiangxi University of TCM, Nanchang, Jiangxi, China.
Evid Based Complement Alternat Med. 2020 Apr 29;2020:8306165. doi: 10.1155/2020/8306165. eCollection 2020.
Acupuncture and moxibustion have been accepted as treatment options for primary dysmenorrhea (PD). So far, several systematic reviews (SRs) and meta-analyses (MAs) have reported on the efficacy and safety of acupuncture and moxibustion in treating PD.
The aim of this study was to critically summarize the evidence from relevant SRs and MAs reporting on the efficacy and safety of acupuncture and moxibustion in treatment of PD.
Seven electronic databases, including Cochrane Database of Systematic Reviews, EMBASE, PubMed, SinoMed, China National Knowledge Infrastructure (CNKI), Chinese Science and Technology Periodical Database (VIP), and Wanfang database, were systematically searched. SRs or MAs about acupuncture for PD published up to May 2019 were included in the analysis. More than two authors independently assessed the quality of the evidence by AMSTAR2, PRISMA, PRISMA-A, and GRADE approach.
A total of 28 SRs and MAs, 281 original studies, reporting on 26,459 female patients were analyzed. The majority of the SRs were of moderate reporting quality and poor methodological quality. Moderate-quality evidence suggested that acupuncture and moxibustion were more effective compared to indomethacin or Fenbid in treating PD. Low-quality evidence suggested that, compared to NSAIDs, acupuncture and moxibustion could relieve pain with less adverse effects.
Acupuncture and moxibustion seem to be effective and safe approaches in treatment of PD; yet, the methodological quality of most of the studies and the quality of evidence were low. Thus, additional studies are required to further confirm these results.
针灸已被公认为原发性痛经（PD）的治疗选择。迄今为止，已有多项系统评价（SR）和荟萃分析（MA）报道了针灸治疗PD的有效性和安全性。
本研究旨在严格总结相关SR和MA中关于针灸治疗PD有效性和安全性的证据。
系统检索了7个电子数据库，包括Cochrane系统评价数据库、EMBASE、PubMed、中国生物医学文献数据库、中国知网、维普中文科技期刊数据库和万方数据库。纳入分析截至2019年5月发表的关于针灸治疗PD的SR或MA。由两名以上作者采用AMSTAR2、PRISMA、PRISMA-A和GRADE方法独立评估证据质量。
共分析了28项SR和MA，涉及281项原始研究，共26459例女性患者。大多数SR报告质量中等，方法学质量较差。中等质量证据表明，与吲哚美辛或芬必得相比，针灸治疗PD更有效。低质量证据表明，与非甾体抗炎药相比，针灸能减轻疼痛且不良反应更少。
针灸似乎是治疗PD的有效且安全的方法；然而，大多数研究的方法学质量和证据质量较低。因此，需要更多研究进一步证实这些结果。
